Holen Sie sich die Stockscreener-App
4.26
8.24%
-0.41
Finanzdaten der Aldeyra Therapeutics Inc-Aktie (ALDX)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Research and Development |
20.76%
4.3035
|
5.4308 | 8.5052 | 7.4233 | 12.44 |
| Operating Income/Loss |
16.66%
-6.6679
|
-8.0011 | -10.17 | -10.43 | -16.14 |
| Nonoperating Income/Loss |
34.02%
0.2064
|
0.3128 | 0.4014 | 0.498 | 1.0246 |
| Income/Loss From Continuing Operations Before Tax |
15.96%
-6.4615
|
-7.6883 | -9.7673 | -9.9295 | -15.11 |
| Income/Loss From Continuing Operations After Tax |
15.96%
-6.4615
|
-7.6883 | -9.7673 | -9.9295 | -15.11 |
Net Income/Loss
|
15.96%
-6.4615
|
-7.6883 | -9.7673 | -9.9295 | -15.11 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
99.94%
0.0358
|
60.13 | 60.05 | 59.89 | 59.53 |
| Diluted Average Shares |
99.94%
0.0358
|
60.13 | 60.05 | 59.89 | 59.53 |
| Basic Earnings Per Share |
23.08%
-0.10
|
-0.13 | -0.16 | -0.17 | -0.25 |
| Diluted Earnings Per Share |
23.08%
-0.10
|
-0.13 | -0.16 | -0.17 | -0.25 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.41%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):